Abstract:The bis-benzimidazole dyes (specifically Hoechst 33258 and the more lipophilic derivative Hoechst 33342) are non-intercalating AT base pair-specific ligands which bind to cellular DNA by non-covalent association with the minor groove. The interaction of dye with cellular DNA is thought to be the principal pathway for the cytotoxic, mutagenic and DNA-damaging properties of such agents. Upon binding and near UV light excitation, dye molecules exhibit fluorescence enhancement such that dye/DNA association and dis… Show more
“…The Ltk-mouse cell line was developed from a subline of the BrdU-resistant strain of the L-M mouse line (Kit et al, 1963). The Ltk-drug-selected subline (Ltk-HoeR415) has been shown to have increased Abcg2 expression and function (Smith et al, 1988(Smith et al, , 2009 mice, and the MEF3.8 M32 subline were provided by Alfred H. Schinkel (Netherlands Cancer Institute). The human ABCG2-expressing sublines used (H460 MX20 and MCF7 FLV500) have been previously characterized (Robey et al, 2001b(Robey et al, , 2004.…”
ABCG2 (also known as breast cancer resistance protein) is an ATP-binding cassette (ABC) transporter localized to the plasma membrane where it mediates the efflux of xenobiotics, including potential therapeutics. Studies investigating Abcg2 function at the blood-brain barrier in mouse models are often compared with human ABCG2 function. It is critical to understand the nature of species differences between mouse and human ABCG2, since extrapolations are made from murine data to humans. Two independent drug-selected cell line pairs expressing human or mouse ABCG2 were compared for efflux of fluorescent substrates using flow cytometry. To this end, we developed and characterized a new mouse Abcg2-expressing subline that demonstrated efflux of known fluorescent ABCG2 substrates and increased resistance to mitoxantrone, which is reduced in the presence of the ABCG2 inhibitor Ko143. Our results indicate that the substrate specificity of human and mouse ABCG2 is very similar. We identified a new human and mouse ABCG2 substrate, a porphyrin analog, purpurin-18 (Pp-18), which is not a substrate for P-glycoprotein or multidrug resistance protein 1. The ability of inhibitors to block efflux activity of ABCG2 was assessed using Pp-18. Inhibitors also demonstrated similar effects on human and mouse ABCG2. Chrysin, benzoflavone, and cyclosporin A inhibited Pp-18 efflux in both human and mouse ABCG2. The similarity of the substrate and inhibitor specificity of human and mouse ABCG2 supports interpretation of mouse models in understanding the clinical, pharmacological, and physiologic roles of ABCG2.
“…The Ltk-mouse cell line was developed from a subline of the BrdU-resistant strain of the L-M mouse line (Kit et al, 1963). The Ltk-drug-selected subline (Ltk-HoeR415) has been shown to have increased Abcg2 expression and function (Smith et al, 1988(Smith et al, , 2009 mice, and the MEF3.8 M32 subline were provided by Alfred H. Schinkel (Netherlands Cancer Institute). The human ABCG2-expressing sublines used (H460 MX20 and MCF7 FLV500) have been previously characterized (Robey et al, 2001b(Robey et al, , 2004.…”
ABCG2 (also known as breast cancer resistance protein) is an ATP-binding cassette (ABC) transporter localized to the plasma membrane where it mediates the efflux of xenobiotics, including potential therapeutics. Studies investigating Abcg2 function at the blood-brain barrier in mouse models are often compared with human ABCG2 function. It is critical to understand the nature of species differences between mouse and human ABCG2, since extrapolations are made from murine data to humans. Two independent drug-selected cell line pairs expressing human or mouse ABCG2 were compared for efflux of fluorescent substrates using flow cytometry. To this end, we developed and characterized a new mouse Abcg2-expressing subline that demonstrated efflux of known fluorescent ABCG2 substrates and increased resistance to mitoxantrone, which is reduced in the presence of the ABCG2 inhibitor Ko143. Our results indicate that the substrate specificity of human and mouse ABCG2 is very similar. We identified a new human and mouse ABCG2 substrate, a porphyrin analog, purpurin-18 (Pp-18), which is not a substrate for P-glycoprotein or multidrug resistance protein 1. The ability of inhibitors to block efflux activity of ABCG2 was assessed using Pp-18. Inhibitors also demonstrated similar effects on human and mouse ABCG2. Chrysin, benzoflavone, and cyclosporin A inhibited Pp-18 efflux in both human and mouse ABCG2. The similarity of the substrate and inhibitor specificity of human and mouse ABCG2 supports interpretation of mouse models in understanding the clinical, pharmacological, and physiologic roles of ABCG2.
“…In this field, recent NMR spectroscopic studies demonstrated that moving the phenolic -OH group of Hoechst 33258 from the para to the meta position provides an additional hydrogen bond between the m -OH and DNA (Parkinson et al, 1994). Controversially, the ethoxy derivative of the phenolic -OH group of Hoechst 33258, named Hoechst 33342, has a lower affinity for DNA than the parent drug (Smith et al, 1988).…”
Quantum mechanical calculations have been used to investigate the molecular conformation of the Hoechst family of DNA-binding dyestuffs. Compounds in which the phenolic substituent adopts either a meta or (tam position were studied. Two different environments have been considered, which are the gas phase and aqueous solution; the conformation in aquaeous solution has been modeled through a selfconsistent reaction field strategy. The results clearly indicate that Hoechst dyes do not adopt a planar conformation and that the degree of planarity is controlled by the external environment. A comparison with experimental data reveals that the conformation of Hoechst dyes in the gas phase is similar to that observed in DNA complexes by X-ray crystallography. In aqueous solution, the conformation deviates from planarity more than in the gas phase, since non-bonded interactions with the solvent offset the loss of conjugative interactions. The role of the drug conformation in the binding mechanism with DNA is discussed.
“…Emission spectrum analysis using narrow band‐pass filters (centered at 400, 450, 500, 555, and 600 nm wavelengths) reveals that dye–DNA dissociation during the incubation of mammalian cells in dye‐free medium results in preferential loss of red versus violet fluorescence. The reverse spectral shift is accelerated when overall dye efflux is enhanced 10‐fold by specific overexpression of ABCG2 (19, 54). This kinetic relationship can be exploited to identify moribund cells which show an “instantaneous” and distinct red‐biased Hoechst 33342–DNA emission signature (55) due to ready access of dye to DNA binding sites.…”
Section: Resultsmentioning
confidence: 99%
“…Such an approach is useful for the FACS isolation of rare SP cells that may require extended instrument run‐times. However, an early study has shown ongoing efflux in SP‐like cells has an initial T ½ of significantly <30 min for the loss of red fluorescence, allocating non‐SP cells to an SP fraction, highlighting the need to control the potential for on‐going dye wash‐out (54).…”
We outline a simple approach involving instrument setup and calibration for the analysis of Hoechst dye 33342-loading in human cell lines for exploring heterogeneity in dye efflux efficiency and the status of side population (SP) A549 lung cancer cells. Dual excitation 488 nm/multiline UV (351-364 nm) flow cytometry was used to confirm ABCG2-specific inhibition of dye efflux using Fumitremorgin C. Transporter gene expression, assayed by qRT-PCR, confirmed higher expression of ABCG2 versus ABCB1, reiterated in a cloned subline. Coexpression of aldehyde dehydrogenase genes ranked as aldehyde dehydrogenase class 1A1 (ALDH1A1) [ ALDH3A1 [ ALDH3, relative expression of all genes was again reiterated in a cloned subline. Permeabilized cells were used to create red:violet (660:405 nm Em wavelengths) ratiometric references for mapping temporal changes in Hoechst 33342-DNA fluorescence in live cells. A live cell ''kinetic SP gate'' tracked progressive dye loading of the whole population and coapplication of the far red ([695 nm wavelength) fluorescing dye DRAQ7 enabled viable cell gating. Kinetic gating revealed a continuum for dye accumulation suggesting that SP enumeration is critically dependent upon the nonlinear relationship of the spectral shift with progressive dye-DNA binding and thus requires accurate definition. To this end, permeabilized cell reference samples permit reproducible instrument setup, guide gate boundaries for SP and compromised cells, and offer a simple means of comparing SP enumeration across laboratory sites/platforms. Our approach reports the dynamic range for the spectral shift, revealing noninformative staining conditions and explaining a source of variability for SP enumeration. We suggest that live cell kinetic sorting of all cells with the same dye:DNA load but with differences in efflux capacity can be used to explore drug resistance capability without prejudice. The SP phenotype should be regarded as a kinetic parameter and not a fixed characteristic-critical for functional assay design and the interpretation of heterogeneity. ' 2012 International Society for Advancement of Cytometry
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.